Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2332833
Max Phase: Preclinical
Molecular Formula: C26H39N9O7
Molecular Weight: 589.65
Molecule Type: Protein
Associated Items:
ID: ALA2332833
Max Phase: Preclinical
Molecular Formula: C26H39N9O7
Molecular Weight: 589.65
Molecule Type: Protein
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)CNC(=O)C[C@@H](C(=O)O)NC(=O)[C@@H](c2ccccc2)NC(=O)[C@@H](CCCCN)NC1=O
Standard InChI: InChI=1S/C26H39N9O7/c27-11-5-4-9-17-23(39)35-21(15-7-2-1-3-8-15)24(40)34-18(25(41)42)13-19(36)31-14-20(37)32-16(22(38)33-17)10-6-12-30-26(28)29/h1-3,7-8,16-18,21H,4-6,9-14,27H2,(H,31,36)(H,32,37)(H,33,38)(H,34,40)(H,35,39)(H,41,42)(H4,28,29,30)/t16-,17+,18-,21+/m0/s1
Standard InChI Key: LMCAPKVVZZHYLE-TWFHAPMSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 589.65 | Molecular Weight (Monoisotopic): 589.2972 | AlogP: -2.70 | #Rotatable Bonds: 10 |
Polar Surface Area: 270.72 | Molecular Species: ZWITTERION | HBA: 8 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.59 | CX Basic pKa: 11.83 | CX LogP: -5.77 | CX LogD: -7.82 |
Aromatic Rings: 1 | Heavy Atoms: 42 | QED Weighted: 0.08 | Np Likeness Score: 0.82 |
1. Bochen A, Marelli UK, Otto E, Pallarola D, Mas-Moruno C, Di Leva FS, Boehm H, Spatz JP, Novellino E, Kessler H, Marinelli L.. (2013) Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids., 56 (4): [PMID:23362923] [10.1021/jm301221x] |
Source(1):